Adco Ceftriaxone Injection

    Adco Ceftriaxone Injection

    S4
    PDF Leaflet Revision Date: 14 April 2025


    Clinical Summary

    Quick overview from the medicine insert

    Indication

    Treatment of various bacterial infections.

    Dosage (summary)

    1-2 g once daily; up to 4 g for severe infections.

    Special Populations

    • Elderly
    • Renal impairment
    • Hepatic impairment

    Pregnancy & Breastfeeding

    Crosses placenta; caution in breastfeeding.

    Key Drug Interactions

    • Aminoglycosides
    • Calcium-containing solutions
    • Vitamin K antagonists

    Contraindications

    • Hypersensitivity to ceftriaxone
    • Premature neonates
    • Hyperbilirubinaemic newborns

    Common side effects

    • Eosinophilia
    • Leucopenia
    • Diarrhoea
    • Rash

    Counselling Points

    • Monitor for signs of allergic reactions
    • Avoid mixing with calcium solutions
    • Report any unusual symptoms

    Serious warnings

    • Risk of precipitation with calcium-containing solutions
    • Serious hypersensitivity reactions
    Important Disclaimer

    The Adco Ceftriaxone Injection professional information leaflet below is the property of Adcock Ingram Critical Care and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

    Healthcare Professionals Only

    This content is for registered healthcare professionals

    Sign in or create a free account to read the full package insert.

    Free for HPCSA-registered professionals. Powered by Medinsert.

    Successfully Stashed! 💊

    This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

    View My Favourites
    WhatsApp Email LinkedIn